Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2017 | 1 |
2018 | 2 |
2019 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Efficacy and safety of serelaxin when added to standard of care in patients with acute heart failure: results from a PROBE study, RELAX-AHF-EU.
Eur J Heart Fail. 2019 Mar;21(3):322-333. doi: 10.1002/ejhf.1368. Epub 2019 Jan 2.
Eur J Heart Fail. 2019.
PMID: 30604559
Free article.
Clinical Trial.
Early Changes in eDiary COPD Symptoms Predict Clinically Relevant Treatment Response at 12 Weeks: Analysis from the CRYSTAL Study.
Kostikas K, Aalamian-Mattheis M, Pagano VA, Nunez X, Fogel R, Patalano F, Clemens A.
Kostikas K, et al. Among authors: aalamian mattheis m.
COPD. 2018 Apr;15(2):185-191. doi: 10.1080/15412555.2018.1445213. Epub 2018 Apr 16.
COPD. 2018.
PMID: 29658810
Clinical Trial.
Item in Clipboard
Treatment response in COPD: does FEV1 say it all? A post hoc analysis of the CRYSTAL study.
Kostikas K, Greulich T, Mackay AJ, Lossi NS, Aalamian-Mattheis M, Nunez X, Pagano VA, Patalano F, Clemens A, Vogelmeier CF.
Kostikas K, et al. Among authors: aalamian mattheis m.
ERJ Open Res. 2019 Feb 25;5(1):00243-2018. doi: 10.1183/23120541.00243-2018. eCollection 2019 Feb.
ERJ Open Res. 2019.
PMID: 30815470
Free PMC article.
Item in Clipboard
Indacaterol/glycopyrronium reduces the risk of clinically important deterioration after direct switch from baseline therapies in patients with moderate COPD: a post hoc analysis of the CRYSTAL study.
Greulich T, Kostikas K, Gaga M, Aalamian-Mattheis M, Lossi NS, Patalano F, Nunez X, Pagano VA, Fogel R, Vogelmeier CF, Clemens A.
Greulich T, et al. Among authors: aalamian mattheis m.
Int J Chron Obstruct Pulmon Dis. 2018 Apr 16;13:1229-1237. doi: 10.2147/COPD.S159732. eCollection 2018.
Int J Chron Obstruct Pulmon Dis. 2018.
PMID: 29713156
Free PMC article.
Clinical Trial.
Item in Clipboard
Efficacy and safety of direct switch to indacaterol/glycopyrronium in patients with moderate COPD: the CRYSTAL open-label randomised trial.
Vogelmeier CF, Gaga M, Aalamian-Mattheis M, Greulich T, Marin JM, Castellani W, Ninane V, Lane S, Nunez X, Patalano F, Clemens A, Kostikas K; CRYSTAL study investigators.
Vogelmeier CF, et al. Among authors: aalamian mattheis m.
Respir Res. 2017 Jul 18;18(1):140. doi: 10.1186/s12931-017-0622-x.
Respir Res. 2017.
PMID: 28720132
Free PMC article.
Clinical Trial.
Item in Clipboard
Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING).
Marin JM, Beeh KM, Clemens A, Castellani W, Schaper L, Saralaya D, Gunstone A, Casamor R, Kostikas K, Aalamian-Mattheis M.
Marin JM, et al. Among authors: aalamian mattheis m.
Int J Chron Obstruct Pulmon Dis. 2016 Jun 28;11:1425-34. doi: 10.2147/COPD.S106127. eCollection 2016.
Int J Chron Obstruct Pulmon Dis. 2016.
PMID: 27418815
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite